Assessment of the therapeutic potential of hesperidin and proteomic resolution of diabetes-mediated neuronal fluctuations expediting Alzheimer's disease

Alzheimer's disease (AD) has been proposed as type III diabetes mellitus (DM). Prognosis and early stage diagnosis of AD is essentially required in diabetic patients to avoid extensive irreversible neuronal damage. Also, simple medication regimes including therapeutics for maintaining glucose l...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	RSC advances 2015-01, Vol.5 (58), p.46965-4698
Hauptverfasser:	Khowal, Sapna, Mustufa, Malik M. A, Chaudhary, Naveen K, Naqvi, Samar Husain, Parvez, Suhel, Jain, Swatantra K, Wajid, Saima
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer's disease Assessments Damage Electrophoresis Fluctuation Hippocampus Proteins Proteomics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!